Lavrijsen AP - Search Results

1

Recommendations on management of EGFR inhibitor-induced skin toxicity: a systematic review.

Baas JM, Krens LL, Guchelaar HJ, Ouwerkerk J, de Jong FA, Lavrijsen AP, Gelderblom H. Baas JM, et al. Among authors: lavrijsen ap. Cancer Treat Rev. 2012 Aug;38(5):505-14. doi: 10.1016/j.ctrv.2011.09.004. Epub 2011 Nov 17. Cancer Treat Rev. 2012. PMID: 22100458 Review.

2

Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors.

Galimont-Collen AF, Vos LE, Lavrijsen AP, Ouwerkerk J, Gelderblom H. Galimont-Collen AF, et al. Among authors: lavrijsen ap. Eur J Cancer. 2007 Mar;43(5):845-51. doi: 10.1016/j.ejca.2006.11.016. Epub 2007 Feb 7. Eur J Cancer. 2007. PMID: 17289377 Review.

3

Emollients and moisturisers for eczema.

van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM. van Zuuren EJ, et al. Cochrane Database Syst Rev. 2017 Feb 6;2(2):CD012119. doi: 10.1002/14651858.CD012119.pub2. Cochrane Database Syst Rev. 2017. PMID: 28166390 Free PMC article. Review.

4

Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin.

Lavrijsen AP, Tieben LM, Ponec M, van der Schroeff JG, van Muijen GN. Lavrijsen AP, et al. Arch Dermatol Res. 1989;281(2):83-8. doi: 10.1007/BF00426583. Arch Dermatol Res. 1989. PMID: 2476080

5

Placebo and nocebo effects for itch and itch-related immune outcomes: A systematic review of animal and human studies.

Meeuwis SH, van Middendorp H, van Laarhoven AIM, van Leijenhorst C, Pacheco-Lopez G, Lavrijsen APM, Veldhuijzen DS, Evers AWM. Meeuwis SH, et al. Among authors: lavrijsen apm. Neurosci Biobehav Rev. 2020 Jun;113:325-337. doi: 10.1016/j.neubiorev.2020.03.025. Epub 2020 Mar 30. Neurosci Biobehav Rev. 2020. PMID: 32240668 Free article. Review.

6

Prospective controlled study of the diagnostic value of skin biopsy in patients with presumed meningococcal disease.

Arend SM, Lavrijsen AP, Kuijken I, van der Plas RN, Kuijper EJ. Arend SM, et al. Among authors: lavrijsen ap. Eur J Clin Microbiol Infect Dis. 2006 Oct;25(10):643-9. doi: 10.1007/s10096-006-0199-7. Eur J Clin Microbiol Infect Dis. 2006. PMID: 16964510 Clinical Trial.

7

Skin disorders indicating peripheral arterial occlusive disease and chronic venous insufficiency in organ transplant recipients.

Buntinx M, Lavrijsen APM, de Fijter JW, Reinders MEJ, Schepers A, Bouwes Bavinck JN. Buntinx M, et al. Among authors: lavrijsen apm. J Diabetes Complications. 2020 Sep;34(9):107623. doi: 10.1016/j.jdiacomp.2020.107623. Epub 2020 May 15. J Diabetes Complications. 2020. PMID: 32466875 Free article.

8

An unusual case of contact dermatitis to procaine.

Bruijn MS, Lavrijsen AP, van Zuuren EJ. Bruijn MS, et al. Among authors: lavrijsen ap. Contact Dermatitis. 2009 Mar;60(3):182-3. doi: 10.1111/j.1600-0536.2008.01504.x. Contact Dermatitis. 2009. PMID: 19260925 No abstract available.

9

[Chloroquine retinopathy].

Nguyen AL, Tan AN, Lavrijsen APM. Nguyen AL, et al. Among authors: lavrijsen apm. Ned Tijdschr Geneeskd. 2018 Dec 17;163:D2904. Ned Tijdschr Geneeskd. 2018. PMID: 30570930 Dutch.

10

Cosmetics and drugs. Is there a need for a third group: cosmeceutics?

Lavrijsen AP, Vermeer BJ. Lavrijsen AP, et al. Br J Dermatol. 1991 May;124(5):503-4. doi: 10.1111/j.1365-2133.1991.tb00636.x. Br J Dermatol. 1991. PMID: 2039730 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page